To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05583552
Title Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy (IMpress)
Acronym IMpress
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GCP-Service International West GmbH
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA | DEU | AUS

Facility Status City State Zip Country Details
Royal Adelaide Hospital Adelaide Australia Details
Royal Brisbane and Women's Hospitals Brisbane Australia Details
Linear Clinical Research Nedlands Australia Details
CHU Nantes - Hôtel Dieu Nantes France Details
Hôpital Archet 1 Nice France Details
Hôpital Saint-Louis Paris France Details
CHU de Toulouse Toulouse France Details
Marien Hospital Düsseldorf Düsseldorf Germany Details
Universität Jena, Medizinische Fakultät Jena Germany Details
Universität Leipzig, Medizinische Fakultät Leipzig Germany Details
Klinikum rechts der Isar München Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field